Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patients with Plexiform Neurofibromas
Abstract
The goal of this Pilot Study is to trail multiple techniques for determining the response of NF1 patients with plexiform neurofibromas to Gleevec (registered) therapy for use in subsequent clinical trials. The impact of this proposal is having a better way to measure/quantify the response of plexiform neurofibromas in NF1 patients to treatment.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2013
- Accession Number
- ADA591162
Entities
People
- Kent Robertson
- Melissa Lee
Organizations
- Indiana University